Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.92%469.96K | 114.39%416.2K | -86.22%194.13K | 387.75%1.41M | -32.09%288.74K | -46.73%425.17K | -4.79%798.11K | 169.76%838.29K | 310.75K |
| Operating revenue | 12.92%469.96K | 114.39%416.2K | -86.22%194.13K | 387.75%1.41M | -32.09%288.74K | -46.73%425.17K | -4.79%798.11K | 169.76%838.29K | --310.75K |
| Cost of revenue | 17.19%63.67K | -45.13%54.33K | -72.89%99.01K | 271.48%365.17K | -54.55%98.3K | -50.94%216.27K | 12.18%440.85K | 100.28%392.98K | 196.22K |
| Gross profit | 12.27%406.29K | 280.45%361.87K | -90.88%95.12K | 447.76%1.04M | -8.84%190.44K | -41.53%208.9K | -19.77%357.26K | 288.81%445.31K | 114.53K |
| Operating expense | -26.40%2.68M | -29.30%3.64M | 13.82%5.15M | 5.55%4.52M | 50.75%4.28M | -5.75%2.84M | -16.80%3.01M | 108.93%3.62M | 1.73M |
| Selling and administrative expenses | 70.40%949.82K | -46.90%557.42K | -40.49%1.05M | 91.25%1.76M | 19.43%922.36K | 13.78%772.3K | -29.51%678.76K | 81.52%962.9K | --530.46K |
| -Selling and marketing expense | --45.32K | ---- | -66.22%143.65K | 105.97%425.18K | 7.03%206.43K | 108.98%192.88K | -50.37%92.29K | 24.62%185.97K | --149.23K |
| -General and administrative expense | 62.27%904.5K | -38.48%557.42K | -32.32%906.06K | 87.00%1.34M | 23.56%715.93K | -1.20%579.42K | -24.52%586.47K | 103.80%776.94K | --381.23K |
| Research and development costs | -52.13%1.19M | 47.18%2.49M | -16.50%1.69M | 3.36%2.02M | 121.02%1.96M | -1.51%886.1K | -10.39%899.67K | --1M | ---- |
| Depreciation amortization depletion | 0.00%6.09K | -98.50%6.09K | 0.00%406.17K | 0.56%406.17K | 3.22%403.91K | 0.13%391.29K | 29.41%390.79K | 116.74%301.98K | --139.33K |
| -Depreciation and amortization | 0.00%6.09K | -98.50%6.09K | 0.00%406.17K | 0.56%406.17K | 3.22%403.91K | 0.13%391.29K | 29.41%390.79K | 116.74%301.98K | --139.33K |
| Provision for doubtful accounts | ---- | -51.79%254.46K | --527.78K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | 59.57%530.95K | -77.40%332.73K | 350.14%1.47M | -67.26%327.14K | 26.14%999.1K | -24.26%792.03K | -22.81%1.05M | 27.26%1.35M | --1.06M |
| Operating profit | 30.68%-2.27M | 35.14%-3.28M | -45.22%-5.05M | 15.02%-3.48M | -55.48%-4.09M | 0.94%-2.63M | 16.38%-2.66M | -96.21%-3.18M | -1.62M |
| Net non-operating interest income (expenses) | -18.19%-92.58K | -35.70%-78.33K | -115.95%-57.72K | 70.01%-26.73K | 1.34%-89.13K | -90.34K | -90.51%74 | 780 | |
| Non-operating interest income | -35.88%2.26K | 565.41%3.52K | --529 | ---- | ---- | --57 | ---- | -90.51%74 | --780 |
| Non-operating interest expense | 15.86%94.84K | 40.51%81.85K | 335.85%58.25K | -85.00%13.37K | -1.40%89.13K | --90.39K | ---- | ---- | ---- |
| Total other finance cost | ---- | ---- | ---- | -85.00%13.37K | --89.13K | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -46.75%635.59K | 118.93%1.19M | -527.11%-6.31M | 29.53%1.48M | 40.23%1.14M | 17.82%812.93K | 53.27%689.98K | 450.18K | |
| Special income (charges) | ---- | ---- | ---7.49M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | --7.49M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -46.75%635.59K | 0.90%1.19M | -19.89%1.18M | 29.53%1.48M | 40.23%1.14M | 17.82%812.93K | 53.27%689.98K | --450.18K | ---- |
| Income before tax | 7.76%-1.73M | 54.34%-1.87M | -152.99%-4.1M | 46.68%-1.62M | -57.06%-3.04M | -4.59%-1.94M | 41.73%-1.85M | -96.03%-3.18M | -1.62M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -173.09%-450.18K | 615.94K |
| Earnings from equity interest net of tax | |||||||||
| Net income | 7.76%-1.73M | 54.34%-1.87M | -152.99%-4.1M | 46.68%-1.62M | -57.06%-3.04M | -4.59%-1.94M | 32.11%-1.85M | -21.94%-2.73M | -2.24M |
| Net income continuous operations | 7.76%-1.73M | 54.34%-1.87M | -152.99%-4.1M | 46.68%-1.62M | -57.06%-3.04M | -4.59%-1.94M | 32.11%-1.85M | -21.94%-2.73M | ---2.24M |
| Noncontrolling interests | |||||||||
| Net income attributable to the company | 7.76%-1.73M | 54.34%-1.87M | -152.99%-4.1M | 46.68%-1.62M | -57.06%-3.04M | -4.59%-1.94M | 32.11%-1.85M | -21.94%-2.73M | -2.24M |
| Preferred stock dividends | |||||||||
| Other under preferred stock dividend | |||||||||
| Net income attributable to common stockholders | 7.76%-1.73M | 54.34%-1.87M | -152.99%-4.1M | 46.68%-1.62M | -57.06%-3.04M | -4.59%-1.94M | 32.11%-1.85M | -21.94%-2.73M | -2.24M |
| Diluted earnings per share | 30.42%-0.0022 | 64.90%-0.0032 | -142.74%-0.009 | 52.33%-0.0037 | 1.14%-0.0078 | 30.80%-0.0079 | 52.79%-0.0114 | 7.85%-0.0241 | -0.0262 |
| Basic earnings per share | 30.42%-0.0022 | 64.90%-0.0032 | -142.74%-0.009 | 52.33%-0.0037 | 1.14%-0.0078 | 30.80%-0.0079 | 52.79%-0.0114 | 7.85%-0.0241 | -0.0262 |
| Dividend per share | |||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |